Cargando…

Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy

BACKGROUND: The aim of this study was to evaluate the psychometric properties of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. METHODS: Patients were assessed with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Hui Lin, Lopez, Violeta, Lam, Simon Ching, Leung, Anthony Kwun To, Li, Yu Chung, Wong, Kam Hung, Au, Joseph Siu Kie, Sundar, Raghav, Chan, Alexandre, De Ng, Terrence Rong, Suen, Lorna Kwai Ping, Chan, Choi Wan, Yorke, Janelle, Molassiotis, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376939/
https://www.ncbi.nlm.nih.gov/pubmed/32703223
http://dx.doi.org/10.1186/s12955-020-01493-y
_version_ 1783562128845701120
author Cheng, Hui Lin
Lopez, Violeta
Lam, Simon Ching
Leung, Anthony Kwun To
Li, Yu Chung
Wong, Kam Hung
Au, Joseph Siu Kie
Sundar, Raghav
Chan, Alexandre
De Ng, Terrence Rong
Suen, Lorna Kwai Ping
Chan, Choi Wan
Yorke, Janelle
Molassiotis, Alex
author_facet Cheng, Hui Lin
Lopez, Violeta
Lam, Simon Ching
Leung, Anthony Kwun To
Li, Yu Chung
Wong, Kam Hung
Au, Joseph Siu Kie
Sundar, Raghav
Chan, Alexandre
De Ng, Terrence Rong
Suen, Lorna Kwai Ping
Chan, Choi Wan
Yorke, Janelle
Molassiotis, Alex
author_sort Cheng, Hui Lin
collection PubMed
description BACKGROUND: The aim of this study was to evaluate the psychometric properties of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. METHODS: Patients were assessed with the FACT/GOG-Ntx subscale, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy Scale 20 (EORTC QLQ-CIPN20), National Cancer Institute -Common Terminology Criteria for Adverse Events (NCI-CTCAE), and light touch test using 10 g monofilament for up to ten assessment points from baseline (prior to initiation of first chemotherapy), after the end of each cycle (up to 6 cycles, 3 weeks per cycle), and at 6, 9, and 12 months after starting chemotherapy. Psychometric analyses included internal consistency reliability, convergent validity, factorial validity, sensitivity to change and responsiveness (minimal clinically important difference, MCID). RESULTS: Cronbach’s alpha coefficients of the FACT/GOG-Ntx subscale were 0.82–0.89 across assessment points. The subscale strongly correlated with the EORTC QLQ-CIPN20 (r = 0.79–0.93) but low-to-moderately correlated with the NCI-CTCAE sensory (r(s) = 0.23–0.45) and motor items (r(s) = 0.15–0.50) as well as the monofilament test (r(s) = 0.23–0.47). The hypothesized 4-factor structure of the FACT/GOG-Ntx subscale was not confirmed at assessment points (χ2/df = 2.26–8.50; all P < 0.001). The subscale exhibited small-to-moderate sensitivity to change (r = 0.17–0.37). The MCIDs were between 1.38 and 3.68. CONCLUSION: The FACT/GOG-Ntx subscale has satisfactory reliability, validity, sensitivity to change and responsiveness to evaluate CIPN in cancer patients. Future research is needed to explore the factorial structure of the FACT/GOG-Ntx subscale as the published four-factor structure was not supported in this study.
format Online
Article
Text
id pubmed-7376939
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73769392020-08-04 Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy Cheng, Hui Lin Lopez, Violeta Lam, Simon Ching Leung, Anthony Kwun To Li, Yu Chung Wong, Kam Hung Au, Joseph Siu Kie Sundar, Raghav Chan, Alexandre De Ng, Terrence Rong Suen, Lorna Kwai Ping Chan, Choi Wan Yorke, Janelle Molassiotis, Alex Health Qual Life Outcomes Research BACKGROUND: The aim of this study was to evaluate the psychometric properties of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. METHODS: Patients were assessed with the FACT/GOG-Ntx subscale, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy Scale 20 (EORTC QLQ-CIPN20), National Cancer Institute -Common Terminology Criteria for Adverse Events (NCI-CTCAE), and light touch test using 10 g monofilament for up to ten assessment points from baseline (prior to initiation of first chemotherapy), after the end of each cycle (up to 6 cycles, 3 weeks per cycle), and at 6, 9, and 12 months after starting chemotherapy. Psychometric analyses included internal consistency reliability, convergent validity, factorial validity, sensitivity to change and responsiveness (minimal clinically important difference, MCID). RESULTS: Cronbach’s alpha coefficients of the FACT/GOG-Ntx subscale were 0.82–0.89 across assessment points. The subscale strongly correlated with the EORTC QLQ-CIPN20 (r = 0.79–0.93) but low-to-moderately correlated with the NCI-CTCAE sensory (r(s) = 0.23–0.45) and motor items (r(s) = 0.15–0.50) as well as the monofilament test (r(s) = 0.23–0.47). The hypothesized 4-factor structure of the FACT/GOG-Ntx subscale was not confirmed at assessment points (χ2/df = 2.26–8.50; all P < 0.001). The subscale exhibited small-to-moderate sensitivity to change (r = 0.17–0.37). The MCIDs were between 1.38 and 3.68. CONCLUSION: The FACT/GOG-Ntx subscale has satisfactory reliability, validity, sensitivity to change and responsiveness to evaluate CIPN in cancer patients. Future research is needed to explore the factorial structure of the FACT/GOG-Ntx subscale as the published four-factor structure was not supported in this study. BioMed Central 2020-07-23 /pmc/articles/PMC7376939/ /pubmed/32703223 http://dx.doi.org/10.1186/s12955-020-01493-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cheng, Hui Lin
Lopez, Violeta
Lam, Simon Ching
Leung, Anthony Kwun To
Li, Yu Chung
Wong, Kam Hung
Au, Joseph Siu Kie
Sundar, Raghav
Chan, Alexandre
De Ng, Terrence Rong
Suen, Lorna Kwai Ping
Chan, Choi Wan
Yorke, Janelle
Molassiotis, Alex
Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
title Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
title_full Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
title_fullStr Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
title_full_unstemmed Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
title_short Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
title_sort psychometric testing of the functional assessment of cancer therapy/gynecologic oncology group—neurotoxicity (fact/gog-ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376939/
https://www.ncbi.nlm.nih.gov/pubmed/32703223
http://dx.doi.org/10.1186/s12955-020-01493-y
work_keys_str_mv AT chenghuilin psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT lopezvioleta psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT lamsimonching psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT leunganthonykwunto psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT liyuchung psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT wongkamhung psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT aujosephsiukie psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT sundarraghav psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT chanalexandre psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT dengterrencerong psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT suenlornakwaiping psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT chanchoiwan psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT yorkejanelle psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy
AT molassiotisalex psychometrictestingofthefunctionalassessmentofcancertherapygynecologiconcologygroupneurotoxicityfactgogntxsubscaleinalongitudinalstudyofcancerpatientstreatedwithchemotherapy